9th Annual Proteins & Antibodies Congress 2016

Over 350 attendees working within Proteins, Antibodies and Biotherapeutics

Over 40 case studies, presentations and panel discussions focused on the key issues in protein expression, purification challenges and therapeutic antibodies. Co-Located with our 4th Annual Biosimilars & Biobetters Congress and 3rd Annual Peptides Congress

4 interactive streams:

  • Protein Purification and Downstream Processing
  • Antibody Discovery and Engineering
  • Protein Expression and Characterisation
  • Therapeutic Applications of Antibodies

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 9th Annual Proteins & Antibodies Congress, taking place in April 2016 in London.

Our Annual Proteins Congress is Europe’s leading Congress on proteins and antibodies, bringing together over 350 senior-level decision makers working at the forefront of research into protein expression, purification and antibody therapeutics in Europe and the US. The Conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an executive platform for high-level scientific discussion for experts working in protein and antibody expression.

Our panel of protein science experts will discuss how to streamline the production of proteins by developing semi-automated pipelines, and how to purify challenging proteins. Our speakers will also address some of the opportunities for optimising purification processes with innovative continuous and integrated processing approaches. On Day Two the focus shifts to protein expression and characterisation challenges; our renowned speakers will offer case studies about enhancing protein stability, complex kinases production, and high throughput characterisation of therapeutic proteins.

Over the two days you will hear from antibody experts who will discuss the latest antibody engineering and therapeutic applications research. Day One focuses on the discovery and engineering of next generation antibodies and will host world-class speakers sharing case studies about novel antibody discovery platforms, antibody library design and lead selection for optimal developability. Day Two will feature high-level discussions about the therapeutic applications of engineered antibodies, including exciting research into antibodies to target ion channels, the application of T cell receptors in cancer therapies, emerging immuno—oncology research and case studies covering the key challenges in therapeutic antibodies.

3rd Annual Peptides Congress, April 2016, London, UK
www.peptides-congress.com

4th Annual Biosimilars & Biobetters Congress, April 2016, London, UK
www.biosimilars-congress.com


Proteins & Antibodies, Peptides and Biosimilars & Biobetters 2015 Sponsors:

  • Engineered Antibodies

Chelatec.jpgIBIS.jpgSanger.jpgAffibody.jpgMetanomics.jpgShire.jpgAIMM.jpgNovozymes.jpgPfizer 2.jpgAgilent copy.jpgSGS.jpgMRC.jpgGlenbervie.jpg

Media Partners